Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
LAKE FOREST, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Month: February 2021
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering
AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”…
Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience
Higher dose cohorts demonstrated 100% overall response rate, resulting in substantial reduction in baseline corticosteroid use…
Tauriga Sciences, Inc. Now Configured to Accept the Following Cryptocurrencies as Payment Options on Its E-Commerce Platform: Bitcoin (BTC), Etherium (ETH), Bitcoin Cash (BCH), Dai (DAI), and Litecoin (LTC)
Tauriga Sciences, Inc. Tauri-Gum Store: E-Commerce Checkout Page The Acceptance of Bitcoin, and These Other…
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line
NEW YORK, NY , Feb. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc….
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy
In addition to preservation of neurocognitive development with ABO-102 in MPS IIIA, new clinical results…
Radius Health, Inc. Provides Abaloparatide Business Update
17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing average…
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV)…
Delisting of AS „Grindeks” shares from the Baltic Main list
Delisting of AS „Grindeks” shares from the Baltic Main list Joint Stock Company “Grindeks” hereby…
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021
Bagsværd, Denmark, 12 February 2021 — This document discloses the data of the transaction(s) made…
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
BURLINGAME, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical…
Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021
Conference Call and Webcast Scheduled for February 18, 2021, 4:30 pm ET PRINCETON, N.J., Feb….
Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day
AUSTIN, TX & DURHAM, NC, Feb. 12, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Vistin Pharma ASA: Invitation to Q4 2020 conference call
Oslo, Norway, 12 February 2020 Vistin Pharma ASA will release its fourth quarter 2020 results…
Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics…
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
George Archos Reports Holdings in Verano Holdings Corp.
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — George Archos (the “Acquiror”), the Chairman, CEO and…
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for…